Business of Supply  Mr. Speaker, I was very pleased to hear my colleague mention the integrity of the finance minister. I have heard many comments from members opposite about the circumstances of the finance minister's birth, but very little comment about the circumstances of the life of service that he has led.

Business of Supply  Mr. Speaker, I thank the member for the opportunity to explain our government's commitment to look at all the ways we can make pharmacare more accessible and more affordable for all Canadians. I have outlined some of the outstanding work that has taken place over the past several years to ensure that we do our very best to make pharmaceuticals available, accessible, and affordable for all Canadians.

Business of Supply  Mr. Speaker, I assure the member that our government is in no way impeded by the motion and remains committed to continuing to move forward to gather the best evidence and obtain the advice of the health committee. We remain committed to protecting the health of all Canadians and to ensuring prescription drugs are affordable and accessible, and we will continue to do that work.

Business of Supply  Mr. Speaker, I thank my colleague for to opportunity to speak a little about the outstanding work being done by our health committee. For the past several weeks, I have had the opportunity to work with our health committee as it has heard important testimony on another bill coming before the House.

Business of Supply  Mr. Speaker, I would like to begin by informing you that I will be splitting my time this afternoon with the member for Thérèse-De Blainville. It is a great pleasure to rise today to discuss the motion tabled by the member for Vancouver Kingsway related to pharmacare. Specifically, I would like to speak about the research that is being supported by the federal government through the Canadian Institutes of Health Research, or CIHR, related to pharmaceuticals.

Business of Supply  Madam Speaker, as a point of clarification, the member has said that he has heard members of the House denounce a national pharmacare system. I want to have a better understanding of how he came to that conclusion, because that is not at all what I have heard today. What I have heard today is an all-party commitment for our health committee to examine this issue and to inform the government of its examination.

Business of Supply  Madam Speaker, I first want to thank the member for Brampton South not only for her remarks but also for her very hard work on the health committee. I want to commend all members of the committee for their work in examining this area and the careful, thoughtful way in which they have approached it.

Medical Assistance in Dying  Mr. Speaker, I want to acknowledge the member opposite and all members who participated in the committee that examined medical assistance in dying for their tireless work, which was very useful in the preparation of the government's legislation on this matter. Our government believes that the legislation permitting medical assistance in dying strikes the right balance between honouring the choices of eligible individuals while protecting the vulnerable.

Medical Assistance in Dying  Mr. Speaker, I would like to thank the member for Saint-Hyacinthe—Bagot for the opportunity to speak on this important issue. Legislation on medical assistance in dying received royal assent on June 17, 2016. The act is designed to strike a balance between personal autonomy for those seeking access to medical assistance in dying and protection of the vulnerable.

Health  Mr. Speaker, I would like to thank the hon. member for Chicoutimi—Le Fjord for his tireless work on behalf of his constituents and for his strong advocacy on behalf of seniors. Our government recognizes the contribution of seniors to our country and is committed to ensuring seniors have access to the health care services they need.

Journalistic Sources Protection Act  Madam Speaker, I am very pleased to have the opportunity to rise in the House today and speak to Bill S-231, an act to amend the Canada Evidence Act and the Criminal Code, otherwise known as the journalistic sources protection act. I would like to take this opportunity to express my gratitude.

Health  Mr. Speaker, our government is committed to strengthening Canada's health care system, including enhancing the affordability, accessibility, and appropriate use of prescription drugs. We look forward to reviewing the parliamentary budget officer's analysis of the cost of a universal national health care program.

Health  Mr. Speaker, by taking bold steps to address affordability, accessibility, and appropriate prescribing, we are working with all of our provincial partners to bring prices down and to improve pharmaceutical management. We look forward to reviewing the parliamentary budget officer's analysis on the cost of a universal health care system.

Marijuana  Mr. Speaker, let us be very clear. What police forces actually said was that they needed access to the resources and the training in order to do the job. Our government has responded. We have committed $274 million to ensure they have what they need to do the job. The cost of delay is continued jeopardy to our children who are using cannabis at the highest rate of any country in the world and billions of dollars more to organized crime.

Justice  Mr. Speaker, our government is committed to ensuring our criminal justice system keeps communities safe, protects victims, and holds offenders to account. As the court in the Cody case reiterated today, every actor in the criminal justice system has a responsibility to ensure criminal proceedings are carried out efficiently and effectively.